Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06918977 · ClinicalTrials.gov registry record · NA
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
A NA study of Diabetes Mellitus, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT06918977: Recruiting NA study of Diabetes Mellitus, sponsored by University of Maryland, Baltimore.
NCT06918977 is a NA study of Diabetes Mellitus that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 50 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06918977, a NA study of Diabetes Mellitus, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.
Primary Outcome
This will be evaluated by decrease HbA1c
Conditions Studied
Interventions
- DEVICE InPen Smart insulin pen
- OTHER traditional/standard insulin pen
Study Locations (2)
Maryland
- Baltimore VA Maryland Center - Baltimore
- VAMHCS, Diabetes Outpatient Clinic - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-01-30 |
| Est. Completion | 2028-05-30 |
| Phase | NA |
What NCT06918977 shows while recruiting
NCT06918977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which InPen Smart insulin pen is the first listed.
NCT06918977 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06918977 about?
NCT06918977 is a clinical study titled "Improving Glycemic Control With Telemedicine and Smart Insulin Pens". Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insuli...
What is the current status of trial NCT06918977?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-01-30. Estimated completion is 2028-05-30.
What conditions does trial NCT06918977 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT06918977?
The interventions under investigation include: InPen Smart insulin pen (DEVICE), traditional/standard insulin pen (OTHER).
Who is sponsoring clinical trial NCT06918977?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06918977 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06918977's enrollment target sits among peer trials
50 151st of 208 higher than 55 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
-
Texts for Diabetes Control Among Homeless Persons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI